Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

10,870 total articles

Costamare Inc. Sets the Date for Its First Quarter 2026 Results Release, Conference Call and Webcast

Costamare Inc. Sets the Date for Its First Quarter 2026 Results Release, Conference Call and Webcast

Costamare Inc., a leading owner and provider of containerships for charter, is set to release its first quarter 2026 financial results on April 29, 2026, before the market opens. Management will host a conference call and webcast to discuss the results. The company operates a fleet of 79 containerships and is publicly traded on the NYSE under ticke…

VivoPower Targets $1.9 Million Annualized EBITDA Uplift from Enrollment of Norway Data Center into Statnett Reserve Markets Demand Response Program

VivoPower Targets $1.9 Million Annualized EBITDA Uplift from Enrollment of Norway Data Center into Statnett Reserve Markets Demand Response Program

VivoPower PLC announced that its Mo i Rana data center in Northern Norway has prequalified 30 MW of capacity for participation in Statnett SF's ancillary services markets, expected to generate approximately $1.9 million in incremental annual EBITDA by fiscal year 2027. This demand response enrollment requires no incremental capital expenditure and …

Norwood Financial Corp announces First Quarter Financial Results

Norwood Financial Corp announces First Quarter Financial Results

Norwood Financial Corp announced first quarter 2026 results highlighting the successful acquisition of Presence Bancshares and completion of a core system conversion. The company reported record net interest income of $24.6 million and tangible book value per share of $22.43. Despite merger-related expenses impacting net income ($3.7 million for th…

NXP Announces Availability of Proxy Materials for the Annual General Meeting of Shareholders to Be Held on June 10, 2026

NXP Announces Availability of Proxy Materials for the Annual General Meeting of Shareholders to Be Held on June 10, 2026

NXP Semiconductors announced the availability of proxy materials for its upcoming Annual General Meeting of Shareholders to be held on June 10, 2026. The company filed its definitive proxy statement and annual report with the SEC and will distribute the notice of internet availability of proxy materials by May 20, 2026. Shareholders can also reques…

Oncolytics Aligns with FDA on Planned Pivotal Anal Cancer Study

Oncolytics Aligns with FDA on Planned Pivotal Anal Cancer Study

Oncolytics Biotech announced FDA alignment on the design of a pivotal randomized controlled trial for pelareorep in patients with unresectable metastatic squamous cell carcinoma of the anal canal who have exhausted standard treatments. The trial aims to support both accelerated and full approval based on multiple endpoints. Previous studies show pr…

New Data Presented at HRS 2026 Show Short-Term Holter Monitoring Misses a Large Proportion of AF Recurrence Post-Ablation and Clinically Significant Arrhythmias in Pregnancy

New Data Presented at HRS 2026 Show Short-Term Holter Monitoring Misses a Large Proportion of AF Recurrence Post-Ablation and Clinically Significant Arrhythmias in Pregnancy

iRhythm Holdings announced new data presented at HRS 2026 showing that short-term Holter monitoring (24-48 hours) misses a significant proportion of atrial fibrillation (AF) recurrences post-ablation and clinically significant arrhythmias during pregnancy. Their Zio ambulatory ECG device, offering continuous monitoring up to 14 days, demonstrated s…

Terns Pharmaceuticals Announces FDA Breakthrough Therapy Designation Granted to TERN-701 for Certain Patients with Chronic Myeloid Leukemia

Terns Pharmaceuticals Announces FDA Breakthrough Therapy Designation Granted to TERN-701 for Certain Patients with Chronic Myeloid Leukemia

Terns Pharmaceuticals announced that the FDA has granted Breakthrough Therapy Designation to TERN-701, an oral allosteric BCR::ABL1 inhibitor targeting adult patients with Philadelphia chromosome-positive chronic myeloid leukemia (CML) in the chronic phase. This designation recognizes TERN-701's potential to offer substantial clinical improvement i…

Safe Pro to Demonstrate AI-Powered Mission Planning at U.S. Army Fort Leonard Wood Maneuver Support Center of Excellence Event

Safe Pro to Demonstrate AI-Powered Mission Planning at U.S. Army Fort Leonard Wood Maneuver Support Center of Excellence Event

Safe Pro Group Inc., a Nasdaq-listed AI defense technology firm, will demonstrate its NODE-X AI edge platform and SPOTD threat detection technology at the U.S. Army's 2026 Joint Protection Combined Expo. These advanced AI tools enable rapid drone image processing for mission planning, threat detection, 3D mapping, and enhanced battlefield situation…

Avalyn Strengthens Leadership Team to Support Long-Term Growth with Appointments of Industry Leaders Adam Golden and Frank Salisbury

Avalyn Strengthens Leadership Team to Support Long-Term Growth with Appointments of Industry Leaders Adam Golden and Frank Salisbury

Avalyn Pharma has strengthened its leadership team by appointing Adam Golden as General Counsel and Head of Business Development, and Frank Salisbury as Senior Vice President of Commercial. These hires bring significant legal, business development, and commercial experience to support Avalyn's clinical advancement and upcoming transition to a publi…

Feedonomics Unlocks Agentic Discovery with Agentic Catalog Exports

Feedonomics Unlocks Agentic Discovery with Agentic Catalog Exports

Commerce (Nasdaq: CMRC) has introduced Feedonomics Agentic Catalog Exports (ACE), an enterprise service enabling merchants to syndicate optimized product catalogs to AI-powered agentic discovery platforms such as OpenAI and Google Gemini. This innovation supports enterprises in becoming 'agent-ready' for AI-driven shopping experiences, reducing eng…

Magnite Unveils New AI-Powered Intelligent Assistance and Agentic Execution Capabilities, Empowering Media Owners and Buyers

Magnite Unveils New AI-Powered Intelligent Assistance and Agentic Execution Capabilities, Empowering Media Owners and Buyers

Magnite announced a significant upgrade of its AI-powered features in its SpringServe platform, introducing intelligent mediation tools such as anomaly detection, demand path optimization, and dynamic pricing to enhance media owners' monetization strategies. Concurrently, Magnite is advancing AI-driven buyer agent tools to streamline campaign activ…

SBC Medical Announces Full-Scale Rollout of Aesthetic Healthcare-Focused Interpretation App "Talk Bridge" Across All Shonan Beauty Clinic Locations

SBC Medical Announces Full-Scale Rollout of Aesthetic Healthcare-Focused Interpretation App "Talk Bridge" Across All Shonan Beauty Clinic Locations

SBC Medical Group Holdings Incorporated announces the full rollout of its aesthetic healthcare interpretation app "Talk Bridge" across all Shonan Beauty Clinic locations. The initiative enhances English-speaking customer support with in-house interpretation services, the creation of the Global Beauty Advisor role, and upgraded English digital marke…

Arcutis Submits Supplemental New Drug Application to the FDA for ZORYVE® (roflumilast) Cream 0.05% to Expand Indication for Treatment of Atopic Dermatitis to Infants Down to 3 Months

Arcutis Submits Supplemental New Drug Application to the FDA for ZORYVE® (roflumilast) Cream 0.05% to Expand Indication for Treatment of Atopic Dermatitis to Infants Down to 3 Months

Arcutis Biotherapeutics has submitted a supplemental New Drug Application to the FDA seeking approval to expand the indication of its topical therapy ZORYVE® (roflumilast) cream 0.05% to treat mild to moderate atopic dermatitis in infants aged 3 months to less than 24 months. This submission is supported by positive Phase 1 and Phase 2 clinical tri…